TrialRheumatology (Oxford, England)2021

Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study).

Frank Behrens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.